SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Matritech (NASDAQ - NMPS)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Philip Aaron Etttedgui who wrote (455)6/12/1997 10:17:00 AM
From: Jon Tara   of 849
 
Phillip, I believe that Matritech has excellent management, but the management doesn't control the stock price.

NMPS ran-up unreasonably last year on a tout from a popular stock-picker. In a way, it's unfortunate that he "discovered" NMPS. The people who follow these guys are looking for instant profits. But NMPS has no instant profits to offer - this is a stock that you have to hold for 5-10 years.

I don't think that anything about this stock is "hype", now that the aformentioned tout is apparently no longer interested in it.

This is a company at the very beginning of their product rollout stage. As is typical of biotechs, gains in sales will come incrementally, a little at a time as the word spreads. But this endorsement by Kaiser Permanente is a huge win for them.

Kaiser Permanente is the cheapest of the cheap, and others look to them to get cost-reducing ideas. To have a diagnostic product that is BOTH more effective than the competition, AND is endorsed by misers at Kaiser puts them in an enviable position.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News